Current developments of coumarin-based anti-cancer agents in medicinal chemistry

S Emami, S Dadashpour - European Journal of Medicinal Chemistry, 2015 - Elsevier
Cancer is one of the leading health hazards and the prominent cause of death in the world.
A number of anticancer agents are currently in clinical practice and used for treatment of …

Biological activity of dihydropyrimidinone (DHPM) derivatives: A systematic review

LHS Matos, FT Masson, LA Simeoni… - European journal of …, 2018 - Elsevier
Dihydropyrimidinones are heterocycles with a pyrimidine moiety in the ring nucleus, which,
in recent decades, have aroused interest in medicinal chemistry due to alleged versatile …

1, 3, 4‐oxadiazole and its derivatives: A review on recent progress in anticancer activities

A Vaidya, D Pathak, K Shah - Chemical biology & drug design, 2021 - Wiley Online Library
Abstract The 1, 3, 4‐oxadiazole nucleus is a biologically imperative scaffold possesses
numerous biological activities. The broad and potent activity of 1, 3, 4‐oxadiazole and their …

Synthesis and differential antiproliferative activity of Biginelli compounds against cancer cell lines: monastrol, oxo-monastrol and oxygenated analogues

D Russowsky, RFS Canto, SAA Sanches… - Bioorganic …, 2006 - Elsevier
The synthesis and differential antiproliferative activity of monastrol (1a), oxo-monastrol (1b)
and eight oxygenated derivatives 3a, b–6a, b on seven human cancer cell lines are …

Targeting the kinesin spindle protein: basic principles and clinical implications

V Sarli, A Giannis - Clinical Cancer Research, 2008 - AACR
Kinesin spindle protein (KSP), a member of the kinesin superfamily of microtubule-based
motors, plays a critical role in mitosis as it mediates centrosome separation and bipolar …

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

TW Corson, A Huang, MS Tsao, BL Gallie - Oncogene, 2005 - nature.com
Abstract Gain of chromosome 1q31–1q32 is seen in> 50% of retinoblastoma and is common
in other tumors. To define the minimal 1q region of gain, we determined genomic copy …

Noncanonical interaction with microtubules via the N-terminal nonmotor domain is critical for the functions of a bidirectional kinesin

SK Singh, N Siegler, H Pandey, N Yanir, M Popov… - Science …, 2024 - science.org
Several kinesin-5 motors (kinesin-5s) exhibit bidirectional motility. The mechanism of such
motility remains unknown. Bidirectional kinesin-5s share a long N-terminal nonmotor …

Discovery of coumarin–monastrol hybrid as potential antibreast tumor-specific agent

KV Sashidhara, SR Avula, K Sharma, GR Palnati… - European journal of …, 2013 - Elsevier
Development of new, targeted antibreast cancer drug which can treat both the hormone
receptor (positive and negative) breast cancers is a very challenging task. The concept of …

Design, synthesis and anticancer activity of new monastrol analogues bearing 1, 3, 4-oxadiazole moiety

FAF Ragab, SM Abou-Seri, SA Abdel-Aziz… - European Journal of …, 2017 - Elsevier
A series of dihydropyrimidine (DHPM) derivatives bearing 1, 3, 4-oxadiazole moiety was
designed and synthesized as monastrol analogues. The new compounds were screened for …

KIF14 mRNA expression is a predictor of grade and outcome in breast cancer

TW Corson, BL Gallie - International journal of cancer, 2006 - Wiley Online Library
Gain of chromosome 1q is a hallmark of breast cancer, and likely reflects oncogene
amplification. We previously identified mitotic kinesin KIF14 (kinesin family member 14) as …